Proximal occlusion of hydrosalpinges by Essure® before assisted reproduction techniques: a French survey

Legendre, Guillaume; Moulin, Julie; Vialard, J.; Ziegler, Dominique de; Fanchin, Rénato; Pouly, Jean Luc; Watrelot, Antoine; Allart, Joelle Belaisch; Massin, Nathalie; Fernandez, H.

doi:10.1016/j.ejogrb.2014.07.020

Cited by 10 publications

(9 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore, 26 studies (from 32 records) were considered eligible. There were four studies with two registers each: Berkkanoglu et al , Cenksoy et al , Galen et al , Matorras et al ; one study with three registers: Mijatovic et al ; and 21 studies with one register each. Data from one study regarding pregnancy outcomes in women with Essure undergoing IVF were also presented in a study reporting on all pregnancies in women with Essure in the same country; we avoided including redundant data in our quantitative analyses.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

High miscarriage rate in women treated with Essure® for hydrosalpinx before embryo transfer: a systematic review and meta‐analysis

Barbosa

Sotiriadis

Papatheodorou

et al. 2016

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

The available evidence suggests that, although Essure prior to ET in women with hydrosalpinx improves the chance of achieving a clinical pregnancy compared with no intervention, it is associated with a higher rate of miscarriage when compared with the other interventions. Although this evidence is based on observational studies, we believe that salpingectomy should be the first option for women who are eligible for videolaparoscopy. However, it is still premature to make recommendations for women who are not eligible for surgery, and randomized controlled trials are needed to clarify which is the best treatment alternative in such a scenario. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.

show abstract

Section: Resultsmentioning

confidence: 99%

“…We tried to contact authors from all studies: additional details were provided for six studies; the authors of three studies confirmed all the extracted data. Four studies were published as abstracts only and the remaining 22 studies were published as full articles.…”

Section: Resultsmentioning

confidence: 99%

High miscarriage rate in women treated with Essure® for hydrosalpinx before embryo transfer: a systematic review and meta‐analysis

Barbosa

Sotiriadis

Papatheodorou

et al. 2016

Ultrasound in Obstet & Gyne

View full text Add to dashboard Cite

show abstract

“…In those patients, the insertion and fibrosis process may be different, since they are nulliparous women whose tubes might have already suffered some kind of inflammation; despite it, Essure placement seems to be an effective method in such cases [10] . The mean number of expanded coils that remained intracavitary extruding from the tubal ostium (4.42 ± 2.7 in the right side and 4.24 ± 2.4) shows that the microinserts were correctly placed in most cases.…”

Section: Discussionmentioning

confidence: 99%

Utility of Three-Dimensional Ultrasonography to Assess the Position of Essure Tubal Occlusion Device and Its Complications

Alvarez-Lopez¹,

Santiago²,

Piñera³

et al. 2016

Gynecol Obstet Invest

View full text Add to dashboard Cite

Background: To determine the utility of three-dimensional (3D) sonography to control the position of hysteroscopic sterilizing device compared to hysterosalpingography (HSG). Methods: A prospective observational study was carried out on 139 patients who underwent hysteroscopic tubal occlusion method between February 2012 and May 2013. Patients underwent 3D ultrasound scan to control device positioning, and they also underwent HSG as an additional control method. Comparison between both methods was carried out. Results: In all, 17 (12.2%) devices were inserted due to a hydrosalpinx and 122 (87.8%) due to sterilization purposes. In 124 (89.2%) cases, sonography correlated completely to HSG findings. Sonography-positive predictive value was 89.5% to detect correct device positioning. Just 4 (2.8%) patients did not present complete tubal occlusion 3 months after device insertion; one of them presented device expulsion, 2 of them presented previous hydrosalpinx (tubal occlusion was confirmed after 6 months), and the last case rejected to undergo further controls but device seem to be effective. Conclusions: 3D sonography seems to be effective for the control of sterilization device positioning, but it also detects insertion complications and device migration. Further studies would be required to assess our findings and the role of sonography in case of hydrosalpinx.

show abstract

“…La mé ta-analyse de Johnson et al avait conclu en 2008 à l'obtention d'une naissance vivante additionnelle pour 8 patientes traité es [95]. L'occlusion proximale de la trompe par la pose hysté roscopique d'implants (Essure 1 ) semble être une option thé rapeutique efficace [96]. Cependant, en l'absence de donné es prospectives sur les issues obsté tricales et dans l'attente des ré sultats de l'é tude randomisé e hollandaise (DESH trial) comparant la pose de microimplant et la salpingectomie, cette option reste à privilé gier pour les patientes à haut risque chirurgical.…”

Section: Coelioscopie Avant Fivunclassified

Y a-t-il une place pour la cœlioscopie dans le parcours en assistance médicale à la procréation ?

Boujenah

Montforte

Hugues

et al. 2015

Gynécologie Obstétrique & Fertilité

View full text Add to dashboard Cite

Proximal occlusion of hydrosalpinges by Essure® before assisted reproduction techniques: a French survey

Cited by 10 publications

References 27 publications

High miscarriage rate in women treated with Essure® for hydrosalpinx before embryo transfer: a systematic review and meta‐analysis

High miscarriage rate in women treated with Essure® for hydrosalpinx before embryo transfer: a systematic review and meta‐analysis

Utility of Three-Dimensional Ultrasonography to Assess the Position of Essure Tubal Occlusion Device and Its Complications

Y a-t-il une place pour la cœlioscopie dans le parcours en assistance médicale à la procréation ?

Contact Info

Product

Resources

About